Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
about
Cellular Plasticity in Prostate Cancer Bone MetastasisComprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell linesQuantum dots for multiplexed detection and characterisation of prostate cancer cells using a scanning near-field optical microscope.Benzo pyrene-induced DNA adducts and gene expression profiles in target and non-target organs for carcinogenesis in mice.Adhesion molecules of detrusor muscle cells are influenced by a hypercholesterolemic diet or bladder outlet obstruction in a Wistar rat modelMetastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.The role of adhesion molecules as biomarkers for the aggressive prostate cancer phenotype.Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis.Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.CEMP1 Induces Transformation in Human Gingival Fibroblasts.Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesisSuppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferationBiomimetic Hydrogels Incorporating Polymeric Cell-Adhesive Peptide To Promote the 3D Assembly of Tumoroids.β-catenin as a prognostic factor for prostate cancer (PCa).T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistanceSteps in prostate cancer progression that lead to bone metastasisIsolated, disseminated and circulating tumour cells in prostate cancer.Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.Role of WNT7B-induced noncanonical pathway in advanced prostate cancer.P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo.Tumor-related interleukins: old validated targets for new anti-cancer drug development.Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer.Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis.Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer.In vitro design of mesenchymal to epithelial transition of prostate cancer metastasis using 3D nanoclay bone-mimetic scaffolds.
P2860
Q28085013-AFDDDF52-7B54-4F07-B26E-12FE3813003AQ33766326-73AB80A7-E62F-4702-BF24-71F6492A0830Q34162912-61AD4D9F-0B55-4CFF-8383-0BBC173F8466Q34402066-FE53D376-0D9B-4713-929F-86E8C2E57960Q35020822-74316402-1629-4570-969D-64F9A2CBE5EDQ35070139-027D2AD1-A60E-49C1-AF11-85FD06A91725Q35072541-8243B0F3-364A-45D8-8F99-0FEFE85A8D2AQ35164684-C95496A8-4781-4FA2-95E4-BE790781196BQ35169094-ADCD0AF8-CA7C-4487-9D0C-027EA3173535Q35642162-6B15B163-73BB-422A-807B-AA472E5F430EQ35672517-DB460953-1901-415A-A1F9-D808661894C3Q36023904-67EE31C3-09EF-4F63-A13C-8DF2D7C46B24Q36355935-A923DF9E-2B80-4BC7-8BFA-0B4904307A4AQ36827512-B8558E8E-636D-421B-BC90-013AFDC0036BQ37086749-F7DD1687-AADE-49EE-923B-C818134BED2EQ37490762-16AA44CB-BEC0-42D8-9730-BA779148A367Q37579140-C857184A-1F4B-4D2D-B629-C275E41A388AQ37601733-74B869C5-FDB8-4C6E-8AD0-633CB568445EQ37848782-985FB47F-E577-4768-807A-204DC636DCA5Q38024987-14EC521C-B861-4B5E-88E5-C19B66C9F62DQ38413261-BE048699-1177-4D22-8C0B-5C66B394A44FQ39021336-426E72DA-03B4-4FEA-8351-4B88A53D2F6FQ39198747-40B970DD-1A46-4943-AC6C-EE771537AADBQ39238903-8095341E-5B49-464C-AE2E-8BE4A4E5AFD5Q40508997-6CBAB090-AA3C-4C2C-A5A6-C56A328EFAB6Q41716360-9EE129F9-1155-4FB2-83CB-FA848A7183F8Q41761066-184F8162-1462-4352-B914-3CC1820AB648Q42444695-848CDF14-4740-4EB9-8231-5C6CF0759E0CQ47177430-BA78761F-F20C-46D2-87AB-B93EF943C2B5Q48028249-FEA022C8-E25D-4179-AAB0-3E08C8F9B18D
P2860
Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Overexpression of E-cadherin a ...... prostate cancer cells in bone.
@en
Overexpression of E-cadherin a ...... prostate cancer cells in bone.
@nl
type
label
Overexpression of E-cadherin a ...... prostate cancer cells in bone.
@en
Overexpression of E-cadherin a ...... prostate cancer cells in bone.
@nl
prefLabel
Overexpression of E-cadherin a ...... prostate cancer cells in bone.
@en
Overexpression of E-cadherin a ...... prostate cancer cells in bone.
@nl
P2093
P2860
P356
P1433
P1476
Overexpression of E-cadherin a ...... prostate cancer cells in bone.
@en
P2093
Ahren Arase
Baisakhi Saha
Denice Tsao-Wei
Lawrence W Jones
S Ashraf Imam
Sarah S Imam
Susan Groshen
Wesley Y Naritoku
P2860
P356
10.1002/PROS.20670
P577
2008-01-01T00:00:00Z